World Bank Document

OFFICIAL
DOCUMENTS

LOAN NUMBER 8873-ID

Loan Agreement

(Indonesia Supporting Primary Health Care Reform (I-SPHERE) Program /
Indonesia Supporting Primary and Referral Health Care Reform (I-

SPHERE) Program)

between

REPUBLIC OF INDONESIA

and

INTERNATIONAL BANK FOR RECONSTRUCTION
AND DEVELOPMENT

2 of 16 LN8873

LOAN AGREEMENT

AGREEMENT dated as of the Signature Date between REPUBLIC OF INDONESIA
("Borrower") and INTERNATIONAL BANK FOR RECONSTRUCTION AND DEVELOPMENT
("Bank"). The Borrower and the Bank hereby agree as follows:

ARTICLE I - GENERAL CONDITIONS; DEFINITIONS

1.01. The General Conditions (as defined in the Appendix to this Agreement) apply to and form part
of this Agreement.

1.02. Unless the context requires otherwise, the capitalized terms used in this Agreement have the
meanings ascribed to them in the General Conditions or in the Appendix to this Agreement.

ARTICLE II- LOAN

2.01. The Bank agrees to lend to the Borrower the amount of one hundred fifty million United States
Dollars (USD 150,000,000), as such amount may be converted from time to time through a
Currency Conversion ("Loan"), to assist in financing the program described in Schedule 1 to

this Agreement ("Program").

2.02. The Borrower may withdraw the proceeds of the Loan in accordance with Section IV of

Schedule 2 to this Agreement. All withdrawals from the Loan Account shall be deposited by
the Bank into an account specified by the Borrower and acceptable to the Bank.

2.03. The Front-end Fee is one quarter of one percent (0.25%) of the Loan amount.

2.04. The Commitment Charge is one quarter of one percent (0.25%) per annum on the Unwithdrawn
Loan Balance.

2.05. The interest rate is the Reference Rate plus the Variable Spread; or such rate as may apply

following a Conversion; subject to Section 3.02(e) of the General Conditions.

2.06. The Payment Dates are January 15 and July 15 in each year.

2.07. The principal amount of the Loan shall be repaid in accordance with Schedule 3 to this

Agreement.

2.08. (a) If on any given day, the Total Exposure exceeds the Standard Exposure Limit (as said
terms are defined in sub-paragraphs (b)(ii) and (b)(iii) of this Section), the Borrower

shall pay to the Bank a surcharge at the rate of one half of one percent (0.5%) per
annum of the Allocated Excess Exposure Amount (as defined in sub-paragraph (b)(i)
of this Section) for each said day ("Exposure Surcharge"). The Exposure Surcharge (if

any) shall be payable semi-annually in arrears on each Payment Date.

3 of 16 LN8873

(b) For purposes of this Section the following terms have the meanings set forth below:

(i) "Allocated Excess Exposure Amount" means for each day during which the
Total Exposure exceeds the Standard Exposure Limit, the product of: (A) the
total amount of said excess; and (B) the ratio of all (or, if the Bank so
determines, a portion) of the Loan to the aggregate amount of all (or the
equivalent portions) of the loans made by the Bank to the Borrower and to other
borrowers guaranteed by the Borrower that are also subject to an exposure
surcharge, as said excess and ratio are reasonably determined from time to time
by the Bank.

(ii) "Standard Exposure Limit" means the standard limit on the Bank's financial
exposure to the Borrower which, if exceeded, would subject the Loan to the
Exposure Surcharge, as determined from time to time by the Bank.

(iii) "Total Exposure" means for any given day, the Bank's total financial exposure
to the Borrower, as reasonably determined by the Bank.

ARTICLE III - PROGRAM

3.01. The Borrower declares its commitment to the objective of the Program. To this end, the
Borrower shall carry out the Program through the Ministry of Health in accordance with the
provisions of Article V of the General Conditions and Schedule 2 to this Agreement.

ARTICLE IV - EFFECTIVENESS; TERMINATION

4.01. The Additional Conditions of Effectiveness consist of the following:

(a) the Ministry of Finance has sent a Letter of Assignment to BPKP to carry out the
verification of DLRs achievement for the Program; and

(b) the Borrower has established the Program Coordinating Unit with terms of references
and resources satisfactory to the Bank.

4.02. The Effectiveness Deadline is the date ninety (90) days after the Signature Date.

ARTICLE V - REPRESENTATIVE; ADDRESSES

5.01. The Borrower's Representative is its Minister of Finance.

4 of 16 LN8873

5.02. For purposes of Section 10.01 of the General Conditions:

(a) the Borrower's address is:

Directorate General of Budget Financing and Risk Management
Ministry of Finance
Gedung Frans Seda
JI. DR. Wahidin Raya No. 1
Jakarta 10710 - Indonesia; and

(b) the Borrower's Electronic Address is:

Facsimile: +62
381-2859

5.03. For purposes of Section 10.01 of the General Conditions:

(a) the Bank's address is:

International Bank for Reconstruction and Development
1818 H Street, N.W.
Washington, D.C. 20433
United States of America; and

(b) the Bank's Electronic Address is:

Facsimile: +1
477-6391

5 of 16 LN8873

AGREED as of the Signature Date.

REPUBLIC OF I SIA

By

Authorized Representative

Name: LUV* ALFRMA4

OWECCRTO C,tNEIAL OF e>U9CiUT
Title: F1NAiNANC AND Zisk MANACIEMENT

Date: JULY 17, 2018

INTERNATIONAL BANK FOR
RECONSTRUCTION AND DEVELOPMENT

By

Autho ed Representative

Name: &eor e Cor6JA

Title: 04tD Outr irt'cof

Date: a / O101?

6 of 16 LN8873

SCHEDULE 1

Program Description

The objective of the Program is to strengthen the performance of Indonesia's primary health

care system.

The Program consists of the following activities, which form part of the Borrower's Healthy

Indonesia Program, as further elaborated in the Borrower's 2015-2019 national mid-term development

plan (RPJMN) and the Ministry of Health's 2015-2019 strategic plan (Minister of Health Decree No.

HK.02.02/MENKES/52/2015):

1 . Strengthening performance monitoring for increased local government and facility

accountability

(a) Developing and publishing performance dashboards to benchmark performance across

Districts and increasing the interoperability of key information systems.

(b) Developing and introducing the use of mHealth to improve the quality of reported data.

2. Improving implementation of national standards for greater local government and facility

performance

(a) Strengthening the credibility and capacity of the KAFKTP to become an independent

commission.

(b) Strengthening the clinical and managerial capacity of - and providing the human

resources required for - the Puskesmas to obtain accreditation, with an additional focus

on Eastern Indonesia.

(c) Strengthening the implementation of priority programs for maternal and child health

(including immunization), nutrition, communicable (especially TB) and non-

communicable diseases.

(d) Providing support for the placement of primary healthcare teams in remote and difficult

to reach areas through the Nusantara Sehat program.

(e) Strengthening the gate-keeping function of primary care - and the referral system -

through expanding the use of an integrated referral information system.

(f) Addressing the key gender gap of maternal mortality through the improvement of

quality of services provided to pregnant women.

(g) Developing and implementing a capacity building program for improving public sector

management functions, including planning and budgeting, for Lagging Districts.

3. Enhancing performance orientation of health financing for better local service delivery

(a) Introducing and implementing performance-based elements in DAK Non-fisik

allocations.

(b) Enhancing the performance-based capitation mechanism to strengthen JKN's roles.

7 of 16 LN8873

SCHEDULE 2

Program Execution

Section I. Implementation Arrangements

A. Program Institutions

1. The Borrower shall establish by December 31, 2018, and thereafter maintain, at all times during

Program implementation, all with staff, functions and resources satisfactory to the Bank:

(a) a Program Steering Committee to provide policy guidance, oversee implementation

and ensure coordination among ministries and subnational agencies, consisting of

representatives of Ministry of Health, BPJS-Health, Ministry of Finance, Ministry of

National Development Planning/Bappenas and Ministry of Home Affairs; and

(b) a Technical Committee to provide overall technical guidance for the Program

implementation, consisting of the directors of relevant units and/or directorates of the

Ministry of Health, Ministry of National Development Planning/Bappenas, BPJS-

Health, Ministry of Finance, Ministry of Home Affairs and KAFKTP.

2. The Borrower shall maintain, at all times during Project implementation, a Program

Coordinating Unit, with staff, functions and resources satisfactory to the Bank, to manage the

Program and provide support for the Program implementation, chaired by the Head of the

Planning Bureau, consisting of a technical working group and a management group.

B. DLR Verification Arrangements

1 . The Borrower shall appoint BPKP to act as an independent verification agent to undertake the

DLR verification process referred to in paragraph 2 below in respect of all DLRs for the

Program in accordance with the terms of reference acceptable to the Bank.

2. The Borrower shall ensure that BPKP shall: (a) verify the data and other evidence supporting

the achievement(s) of one or more DLR(s) under Categories (1) through (10) as set forth in the

table in Section IV.A.2 of this Schedule 2 and recommend corresponding payments to be made,

as applicable, in accordance with the Verification Protocol agreed with the Bank; and (b)

submit to the Bank the corresponding verification reports in a timely manner in form and

substance satisfactory to the Bank.

8 of 16 LN8873

C. Program Action Plan

1. The Borrower shall:

(a) undertake the actions set forth in the Program Action Plan in a manner satisfactory to
the Bank;

(b) except as the Bank and the Borrower shall otherwise agree in writing, not assign,
amend, abrogate, or waive, or permit to be assigned, amended, abrogated, or waived,
the Program Action Plan, or any provision thereof; and

(c) maintain policies and procedures adequate to enable it to monitor and evaluate, in
accordance with guidelines acceptable to the Bank, the implementation of the Program
Action Plan.

Section II. Excluded Activities

The Borrower shall ensure that the Program excludes any activities which:

A. in the opinion of the Bank, are likely to have significant adverse impacts that are
sensitive, diverse, or unprecedented on the environment and/or affected people; or

B. involve the procurement of: (1) works, estimated to cost seventy five million UnitAed
States Dollars (USD 75,000,000) equivalent or more per contract; (2) goods, estimated
to cost fifty million United States Dollars (USD 50,000,000) equivalent or more per
contract; (3) non-consulting services, estimated to cost fifty million United States
Dollars (USD 50,000,000) equivalent or more per contract; or (4) consulting services,
estimated to cost twenty million United States Dollars (USD 20,000,000) equivalent or
more per contract.

Section III. Program Monitoring, Reporting and Evaluation

1 . The Borrower shall furnish to the Bank each Program Report not later than forty-five (45) days
after the end of each calendar semester, covering the calendar semester.

2. Not later than June 30, 2021, the Borrower, through the Ministry of Health, shall, in
conjunction with the Bank, carry out a mid-term review of the Program ("Mid-term Review"),
covering the progress achieved in the implementation of the Program. To this end, the
Borrower shall prepare and furnish to the Bank not less than three (3) months prior to the
beginning of the Mid-term Review, a report integrating the results of the Program's monitoring
and evaluation activities on the progress achieved in the carrying out of the Program during the
period preceding the date of such report, and setting out the measures recommended to ensure
the efficient carrying out of the Program and the achievement of the objective of the Program
during the period following such date. Following the Mid-term Review, the Borrower shall act
promptly and diligently in order to take, or cause to be taken, any corrective action deemed
necessary by the Bank to remedy any shortcoming noted in the carrying out of the Program in
furtherance of the objective of the Program.

9 of 16 LN8873

Section IV. Withdrawal of Loan Proceeds

A. General

1. Without limitation upon the provisions of Article II of the General Conditions and in

accordance with the Disbursement and Financial Information Letter, the Borrower may

withdraw the proceeds of the Loan to finance Program Expenditures, on the basis of the results

("Disbursement Linked Results" or "DLRs") achieved by the Borrower, as measured against

specific indicators ("Disbursement Linked Indicators" or "DLIs"); all as set forth in the table

in paragraph 2 of this Part A.

2. The following table specifies each category of withdrawal of the proceeds of the Loan

(including the Disbursement Linked Indicators as applicable) ("Category"), the Disbursement

Linked Results for each Category (as applicable), and the allocation of the amounts of the Loan

to each Category:

Category Disbursement Linked Amount of Formula

(including Disbursement Result (as applicable) the Loan
Linked Indicator as Allocated

applicable) (expressed in
USD)

(1) DLI #1: Districts DLR #1.1: 1,500,000 DLR #1.1:

covered in the Ministry of Performance dashboard $1,500,000

Health's published designed and its guidelines

performance dashboard issued

DLR#1.2: 13,500,000 DLR#1.2:
Target: 90% Unit Price: $150,000
(Baseline 0%) for each percentage

point (1%) increase
(2) DLI #2: Puskesmas DLR #2.1: 500,000 DLR #2.1:

using mHealth application mHealth implementation $500,000

to support enhanced PIS- plan for PIS-PK completed

PK
DLR #2.2: 1,000,000 DLR #2.2:
mHealth for PIS-PK $1,000,000
designed and field-tested

DLR #2.3: 6,000,000 DLR #2.3:
Target: 1,500 Puskesmas Unit Price:

(Baseline: 0 Puskesmas) $4,000 for each
Puskesmas

(3) DLI #3: Puskesmas DLR #3: 22,500,000 DLR #3:

that have received higher Target: 1,996 Puskesmas Unit Price: $15,000

levels of accreditation (Baseline: 496 Puskesmas) for each newly higher

I , level accredited

10 of 16 LN8873

Puskesmas above the

baseline

(4) DLI #4: Puskesmas DLR #4: 7,500,000 DLR #4:
that have been accredited Target: 466 Puskesmas Unit Price: $18,750

(for basic levels) in (Baseline: 66 Puskesmas) for each newly

Eastern Indonesia accredited Puskesmas
above the baseline

(5) DLI #5: KAFKTP DLR #5.1: 2,500,000 DLR #5.1:

functioning as an Roadmap for independent $2,500,000

independent commission commission is produced

DLR #5.2: 5,000,000 DLR #5.2:
Costed business plan and $5,000,000
by-laws submitted

DLR #5.3: 2,000,000 DLR #5.3:
Decree issued establishing $2,000,000

the independent commission

DLR #5.4:
75% of KAFKTP staff 10,000,000 DLR #5.4:
appointed $10,000,000

DLR #5.5:
KAFKTP operating in 3,000,000 DLR #5.5:
accordance with its bylaws $3,000,000

(6) DLI #6: Lagging DLR #6.1: 1,500,000 DLR #6.1:

Districts that have Updated MOH guidelines $1,500,000
produced improved annual and training modules issued

plans and budgets
DLR #6.2: 6,000,000 DLR #6.2:
Target: 120 Lagging Unit Price: $50,000
Districts for each Lagging

(Baseline: 0 Lagging District

District)

(7) DLI #7: Special Health DLR #7: 7,500,000 DLR #7:

Workers Teams deployed Target: 1,039 Unit Price:

(Baseline: 439) $12,500 for each

Special Health
Workers Team
deployed above the

baseline

11 of 16 LN8873

(8) DLI #8: Primary care DLR #8.1: 6,000,000 DLR #8.1:
providers implementing Joint Ministry of Health and $6,000,000
performance-based JKN BPJS agreement on
capitation performance-based JKN

capitation signed

DLR #8.2: 18,000,000 DLR #8.2:
Target: 60% of the number Unit Price:
of primary health care $300,000 for each

providers enrolled with percentage point

BPJS (1%) increase
(Baseline: 0%)

(9) DLI #9: Districts DLR #9.1: 1,000,000 DLR #9.1:
showing an improvement Enhanced performance- 1,000,000

on at least half of the based DAK Non-fisik

performance indicators in designed

the enhanced DAK Non-

fisik DLR #9.2: 2,500,000 DLR #9.2:
Enhanced DAK Non-fisik 2,500,000
baseline data collected

DLR #9.3: 2,500,000 DLR #9.3:
DAK Non-fisik allocated 2,500,000
based on performance

DLR #9.4: 24,000,000 DLR #9.4:
Target: 60% Unit Price:

(Baseline: 0%) $400,000 for each
percentage point
(1%) increase

(10) DLI #10: Provinces DLR #10.1: 500,000 DLR #10.1:

that are using an IRIS designed 500,000
integrated referral
information system (IRIS) DLR#10.2: 1,000,000 DLR#10.2:

Software application for 1,000,000
IRIS completed

DLR#10.3: 4,500,000 DLR#10.3:
IRIS implemented in 5 Unit Price: $900,000
Provinces for each additional

Province

(Baseline: 0 Province)

TOTAL AMOUNT 150,000,000

12 of 16 LN8873

B. Withdrawal Conditions; Withdrawal Period

1. Notwithstanding the provisions of Part A of this Section, no withdrawal shall be made:

(a) on the basis of DLRs achieved prior to the Signature Date; or/and

(b) for any DLR, until and unless the Borrower has furnished evidence satisfactory to the
Bank that said DLR has been achieved.

2. Notwithstanding the provisions of Part B. 1(b) of this Section, the Borrower may withdraw an
amount not to exceed $37,500,000 as an advance; provided, however, that if, in the opinion of
the Bank, the DLRs for that amount are not achieved (or only partially achieved) by the Closing
Date, the Borrower shall refund such advance to the Bank promptly upon notice thereof by the
Bank. Except as otherwise agreed with the Borrower, the Bank shall cancel the amount so
refunded. Any further withdrawals requested as an advance under any Category shall be
permitted only on such terms and conditions as the Bank shall specify by notice to the
Borrower.

3. Notwithstanding the provisions of Part B. 1(b) of this Section, the amount of the Loan to be
withdrawn upon the verified achievement of any DLR, shall be calculated, in accordance with
the Formula.

4. Notwithstanding the provisions of Part B. 1(b) of this Section, if any of the DLRs has not been
achieved, the Bank may, by notice to the Borrower: (a) reallocate all or a portion of the
proceeds of the Loan then allocated to said DLR to any other DLR; and/or (b) cancel all or a
portion of the proceeds of the Loan then allocated to said DLR.

5. The Closing Date is April 30, 2024.

13 of 16 LN8873

SCHEDULE 3

Amortization Schedule
Commitment-Linked Amortization Repayment Schedule

The following table sets forth the Principal Payment Dates of the Loan and the percentage of the total
principal amount of the Loan payable on each Principal Payment Date ("Installment Share").

Commitment Principal Repayments

Principal Payment Date Installment Share
January 15, 2025 6.58%

July 15, 2025 6.66%

January 15, 2026 6.75%

July 15, 2026 6.83%

January 15, 2027 6.92%

July 15, 2027 7.00%

January 15, 2028 7.09%

July 15, 2028 7.18%

January 15, 2029 7.27%

July 15, 2029 7.36%

January 15, 2030 7.45%

July 15, 2030 7.54%

January 15, 2031 7.64%

July 15, 2031 7.73%

14 of 16 LN8873

APPENDIX

Definitions

1. "Anti-corruption Guidelines" means, for purposes of paragraph 5 of the Appendix to the
General Conditions, the Bank's "Guidelines on Preventing and Combating Fraud and
Corruption in Program-for-Results Financing," dated February 1, 2012, and revised July 10,
2015.

2. "BPJS" or "Badan Penyelenggara Jaminan Sosial' means the Borrower's national social
insurance agency, which is established and operating in accordance with the Borrower's Law
No. 24 of 2011, or any successor thereto.

3. "BPJS-Health" or "BPJS-Kesehatan" means a sub-division of BPJS responsible for providing
health insurance, or any successor thereto.

4. "BPKP" or "Badan Pengawas Keuangan dan Pembangunan" means the Borrower's agency
responsible for finance and development supervision, or any successor thereto.

5. "Category" means a category set forth in the table in Section IV.A.2 of Schedule 2 to this
Agreement.

6. "DAK" or "Dana Alokasi Khusus" means funds allocated in the Borrower budget for specific
regions for the purposes of financing specific activities that fall under regional autonomy.

7. "DAK Non-fisik" means DAK for non-physical activities, which in the health sector finances
specified operational expenditures, i.e. health operational assistance (for preventive and
promotive serves), childbirth services guarantee, Puskesmas accreditation and hospital
accreditation).

8. "Disbursement Linked Indicator" or "DLI" means in respect of a given Category, the indicator
related to said Category as set forth in the table in Section IV.A.2 of Schedule 2 to this

Agreement, and "DLIs" means, collectively, all such DLIs.

9. "Disbursement Linked Result" or "DLR" means in respect of a given Category, the result under
said Category as set forth in the table in Section IV.A.2 of Schedule 2 to this Agreement, on
the basis of the achievement of which, the amount of the Loan allocated to said result may be
withdrawn in accordance with the provisions of said Section IV, and "DLRs" means,
collectively, all such DLRs.

10. "District" means an administrative sub-division of a Province, and "Districts" means,
collectively, all such Districts.

11. "Eastern Indonesia" means the eastern part of the territory of the Republic of Indonesia, which,
for the purpose of this Program, consists of Maluku, NTT and Papua Provinces.

15 of 16 LN8873

12. "Formula" means the measure for calculating disbursements against DLRs, given by the
product of the Unit Price per the actual target achieved, as determined by the Bank in
accordance with the table in Section IV.A.2 of Schedule 2 to this Agreement.

13. "General Conditions" means the "International Bank for Reconstruction and Development
General Conditions for IBRD Financing, Program-for-Results Financing", dated July 14, 2017.

14. "Head of the Planning Bureau" means the executive head responsible for planning in the
Ministry of Health, or any successor thereto.

15. "Healthy Indonesia Program" or "Program Indonesia Sehat" means the Borrower's program,
operating pursuant to the Borrower's 2015-2019 national mid-term development plan and the
Ministry of Health's 2015-2019 strategic plan (Minister of Health's Decree No.
HK.02.02/MENKES/52/2015), or any successor(s) thereto acceptable to the Bank.

16. "IRIS" means the Borrower's integrated referral information system to track and refer patients
from primary care to hospital care.

17. "JKN" or "Jaminan Kesehatan Nasional' means the Borrower's national health insurance
program, established and operating pursuant to the Borrower's Law No. 40 of 2004, or any
successor thereto.

18. "KAFKTP" or "Komisi Akreditasi Fasilitas Kesehatan Tingkat Pertama" means the
Borrower's accreditation commission for primary health care facilities, which is established
and operating pursuant to the Minister of Health's decree no. HK.02.02/MKES/432/2016 and
the Minister of Health's Regulation No. 46 of 2015, or any successor thereto.

19. "Lagging District" means one out of 120 Districts with the lowest absorption capacity of DAK,
and "Lagging Districts" means, collectively, all such Districts.

20. "Letter of Assignment" means the letter to be sent by the Ministry of Finance to BPKP,
providing for the arrangements and terms of reference for the verification of the DLRs of the

Program, acceptable to the Bank.

21. "mHealth" means the mobile application to be developed to record specific service delivery
interventions and develop healthy family indices based on a pre-determined set of indicators.

22. "Ministry of National Development Planning/Bappenas" or "Badan Perencanaan

Pembangunan Nasionar' means the Borrower's national development planning agency, or any

successor thereto.

23. "Ministry of Finance" means the Borrower's ministry responsible for finance, or any successor
thereto.

24. "Ministry of Health" means the Borrower's ministry responsible for health, or any successor
thereto.

16 of 16 LN8873

25. "Ministry of Home Affairs" means the Borrower's ministry responsible for home affairs, or
any successor thereto.

26. "PIS-PK" or "Program Indonesia Sehat melalui Pendekatan Keluarga" means the
implementation of key health interventions such as prevention and promotion through family
approaches, under the Healthy Indonesia Program.

27. "President" means the Borrower's head of state and head of executive.

28. "Presidential Regulation" means the regulation issued by the Borrower's President.

29. "Program Action Plan" means the Borrower's plan dated May 17, 2018 and referred to in
Section I.C of Schedule 2 to this Agreement, as may be amended from time to time with the
agreement of the Bank.

30. "Program Coordinating Unit" means the unit to be established in accordance with Section I.A.2
of Schedule 2 to this Agreement.

31. "Program Steering Committee" means the committee to be established in accordance with
Section I.A. 1(a) of Schedule 2 to this Agreement.

32. "Province" means an administrative division of the Borrower, and "Provinces" means,
collectively, all such Provinces.

33. "Puskesmas" or "Pusat Kesehatan Masyarakat' means any of the Borrower's public primary
health centers, which are operating pursuant to the Minister of Health's Regulation No. 75 of
2014, or any successor thereto.

34. "RPJMN" or "Rencana Pembangunan Jangka Menengah Nasional" means the Borrower's
national medium-term development plan, as regulated in the Borrower's Presidential
Regulation No. 2 of 2015, as amended.

35. "Signature Date" means the later of the two dates on which the Borrower and the Bank signed
this Agreement and such definition applies to all references to "the date of the Loan
Agreement" in the General Conditions.

36. "Special Health Workers Team" means the team consisting of health workers on special
assignment to fill Puskesmas workforce gaps in targeted locations, and "Special Health
Workers Teams" means, collectively, all such teams.

37. "TB" means tuberculosis.

38. "Technical Committee" means the committee to be established in accordance with Section
I.A. 1(b) of Schedule 2 to this Agreement.

39. "Unit Price" means, in respect of any DLR, the amount set forth in the fourth column of the
table in Section IV.A.2 of Schedule 2 to this Agreement.

40. "Verification Protocol" means the protocol setting forth the actions and mechanism required
for the verification of DLRs, as agreed with the Bank, dated April 20, 2018, as the same may
be amended from time to time with the agreement of the Bank.